Company: BNBX
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0001104659-25-030551
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 5.08
Chunk 0
---
Item 5.08. Shareholder Director Nominations.

On March 30, 2025, the Board of Directors of Applied DNA Sciences,
Inc. (the “ Company”) resolved to hold its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) on May
22, 2025. The 2025 Annual Meeting will be held virtually online by means of remote communication.

The record date for the 2025 Annual Meeting is April 3, 2025. Stockholders
owning the Company’s common stock at the close of business on the record date, or their legal proxy holders, are entitled to vote
at the 2025 Annual Meeting. The Company, however, reserves the right to change the record date or the meeting date.

Because the date of the 2025 Annual Meeting has been changed by more
than 30 days from the date of the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”), the deadline
for stockholders’ nominations or proposals for consideration at the 2025 Annual Meeting set forth in the Company’s proxy statement
for the 2024 Annual Meeting no longer applies. As such, the Company is filing this Current Report on Form 8-K to inform stockholders of
this change and to provide the due date for the submission of any qualified stockholder proposals or qualified stockholder director nominations.

Stockholders of the Company who wish to have a proposal considered
for inclusion in the Company’s proxy materials for the 2025 Annual Meeting pursuant to Rule 14a-8 under the Exchange Act (“ Rule
14a-8”) must ensure that such proposal is delivered or mailed to and received by the Company’s Corporate Secretary at Applied
DNA Sciences, Inc., 50 Health Sciences Drive, Stony Brook, NY 11790, no later than April 11, 2025, which the Company has determined to
be a reasonable time before it expects to begin to print and distribute its proxy materials. Such proposals must comply with all applicable
procedures and requirements of Rule 14a-8.

Any stockholder who intends to submit a director nomination or who
intends to submit a proposal regarding any other matter of business at the 2025 Annual Meeting other than in accordance with Rule 14a-8
or otherwise must similarly make sure that such nomination or proposal and related notice comply with all applicable rules of the Securities
and Exchange Commission, the Delaware General Corporation Law and the Company’s By